drug

Atypical antipsychotics (AAP)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Manuel Jesús Cuesta Zurita
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.
NCT07371325—Completed
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
NCT00488891—Terminated

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Manuel Jesús Cuesta Zurita
company
trial
Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.
NA
trial
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
trial
indication
Schizophrenia
indication
Postbiotic Supplement
indication
SCHIZOPHRENIA 1 (Disorder)
indication
Schizophrenia
indication